Company Filing History:
Years Active: 2015-2020
Title: Kan Chiba: Innovator in Cytokine Research and Cancer Detection
Introduction
Kan Chiba is a prominent inventor based in Chiba, Japan. He has made significant contributions to the fields of cytokine research and cancer detection. With a total of 4 patents, Chiba's work focuses on innovative methods that enhance our understanding of metabolic activities and cancer markers.
Latest Patents
Chiba's latest patents include a method for evaluating the effect of cytokines on the metabolic activity of cytochrome P450. This technique utilizes an established hepatocyte cell line to assess how cytokines influence metabolic processes. The method involves culturing hepatocyte spheroids and evaluating their interaction with test solutions containing cytokines over a specified time frame. Another notable patent is related to an alternative splicing variant of OATP1B3 mRNA, which serves as a novel tumor marker. This invention provides a method for measuring this variant in biological samples, aiding in cancer detection and the screening of therapeutic agents.
Career Highlights
Throughout his career, Kan Chiba has worked with esteemed institutions such as Chiba University and Corning Incorporated. His research has significantly advanced the understanding of cytokine interactions and their implications in drug metabolism and cancer treatment.
Collaborations
Chiba has collaborated with notable colleagues, including Tomomi Furihata and Sayaka Matsumoto. These partnerships have fostered innovative research and development in his field.
Conclusion
Kan Chiba's contributions to cytokine research and cancer detection exemplify the impact of innovative thinking in science. His patents reflect a commitment to advancing medical knowledge and improving therapeutic strategies.